Allarity Therapeutics, Inc.
ALLR
$1.61
-$0.15-8.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.08% | 63.34% | 35.69% | -611.48% | 57.61% |
| Total Depreciation and Amortization | 9.09% | 1,000.00% | -80.00% | 400.00% | -50.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.24% | -45.88% | -96.34% | 545.31% | -369.21% |
| Change in Net Operating Assets | -2,195.30% | -103.81% | 223.76% | 12.04% | -224.28% |
| Cash from Operations | -104.06% | 16.22% | 41.10% | 25.48% | -422.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -100.00% | 163.12% | -22.01% | -80.36% | 69,022.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | 100.00% | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -123.02% | 163.12% | -13.00% | -81.50% | 1,806.45% |
| Foreign Exchange rate Adjustments | -549.30% | -184.37% | 273.85% | -132.14% | -150.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -221.20% | 663.64% | 238.96% | -104.07% | 12,859.59% |